Global Facial Injectable Market

Global Facial Injectable Market Size, Trends, and Analysis- Forecasts To 2026 By Product (Hyaluronic Acid (HA), Calcium Hydroxyapatite (CaHA), Botulinum Toxin Type A, Collagen, Polymer Fillers), By Application (Therapeutics, Aesthetics), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on May 19 2024 with the latest and most recent market numbers

Facial Injectable Market: Insights

Dermal fillers, commonly known as facial injectables, are drugs that aid in bioengineering or facial revitalization. When people become older, their facial skin lacks subcutaneous fat and is drawn closer to their facial functioning muscles, resulting in more pronounced wrinkles and fine lines. This also causes facial skin to stretch, which contributes to volume reduction. These problems may be resolved by using facial injectables or dermal fillers, which aid in the treatment of early symptoms of aging or add benefit to a facial rejuvenation procedure.

The growing beauty awareness and the number of beauty treatments, the launch of cost-effective facial injectables, and the elderly population are all boosting the facial injectables industry. The cosmetics market is thriving in the present decade, with unprecedented three-fold growth in turnover from the past several decades. The overall number of non-surgical treatments, such as dermal filler injections and wrinkle relaxer, has increased specifically. This pattern is largely due to technological benefits such as fast recovery, reduced infection risk, zero blood loss, and lower average procedure costs. As a result, the global demand has grown as the number of cosmetic treatments has increased.

Furthermore, there is a steady increase in the geriatric demographic, which continues to drive business demand. In addition to the aging population, a younger demographic has been also drawn to the cosmetics industry in order to look attractive.

Because of the current COVID-19 pandemic, people are spending more time on video conferencing. Known as the 'Zoom Boom,' a growing number of people are becoming more conscious of their looks. This has resulted in a rise in the cosmetic surgery market, with Botox being one of the most common treatments. Cosmetic surgeries are also becoming more common with patients due to the ease with which they can heal while living at home. As a result, after the pandemic, the demand for facial injectables exploded.

The rising cost of surgery and stringent treatment laws are likely to restrict the development of the global facial injectable industry. The number of adverse effects associated with current facial injections has dramatically slowed the sector's progress. Injection filler industry development is also hampered by the high cost of cosmetic surgery. Furthermore, the prevalence of unauthorized professionals is expected to have a significant detrimental impact on injection filler demand in the forthcoming years. Following minimally invasive surgery, there is an increase in the number of problems.

Their usage has the same risks as any other medical procedure. redness, tenderness, swelling, infection, and discomfort in or under the skin (granulomas or nodules) may need oral antibiotics surgical removal, or injection, so one should be informed of their weaknesses and potential risks.

global facial injectable market

Facial Injectable Market: By Product

Owing to the growing use of dermal fillers in cosmetic surgeries, hyaluronic acid has the highest market share. The category is growing due to rising demand for cosmetic procedures and an increase in the number of facial treatments.

Furthermore, hyaluronic acid has numerous advantages, including increased hydration, improved elasticity, and protection from UV damage by reversing free radical damage. These factors contribute significantly to the overall growth of the hyaluronic acid industry. It is also clear that the industry for hyaluronic acid is rising rapidly, indicating that the market will continue to rise steadily in the near future.

In 2020, botulinum toxin type A dominated the market with a significant share. Injectables and fillers, such as the popular Botox, are becoming more famous among middle-aged women who choose to alleviate the symptoms of aging.

Facial Injectable Market: By Application

The demand for facial injectables has been divided into aesthetics and therapeutics based on application. Due to the growing usage of facial injectables for beauty treatments such as wrinkles on the face, facial lines, and lip lines, the aesthetics segment led the market in 2020 with the major revenue share and is projected to retain its dominance during the anticipated timeframe. In the near future, the market for facial injectables for aesthetic purposes is projected to rise due to an increasing fascination for personal beauty and growth in spending power among the middle-class population in emerging economies like India.

asia pacific facial injectable market

Facial Injectable Market: By Region

The global facial injectable market is expected to be dominated by North America. North America's supremacy in the facial injectable industry can be attributed to a rise in cosmetic treatment expenditure to a large extent. During the projected timeframe, the presence of a large geriatric population in the United States and Canada is expected to drive the growth for facial injectables. Furthermore, the awareness of forward-looking cosmetic therapies and a growing focus on physical appearances are expected to drive business development.

During the coming years, Asia Pacific is expected to develop at the fastest pace. South Korea, Australia, and India are among the countries that support the region. In these emerging nations, a growing emphasis on physical attractiveness is projected to drive the market for facial injectable treatments. During the forthcoming years, India is expected to rise at the fastest pace. The Asia Pacific region is the fastest-growing market due to rising demand for aesthetic procedures, a decreasing social stigma around aesthetic procedures, evolving healthcare infrastructure, and the availability of low-cost procedures.

Facial Injectable Market: Share & Competitor Analysis

Some of the major players in the global facial injectable market include Suneva Medical, Inc., ALLERGAN, Sinclair Pharma, Merz Pharma, Prollenium Medical Technologies Inc., Medytox, Inc., Galderma S.A., Bloomage BioTechnology Corporation Limited, Anika Therapeutics, Inc., and Ipse.

Please note: This is not an exhaustive list of companies profiled in the report.

In April 2019, At the 17th Aesthetic & Anti-Aging World Congress (AMWC) in Monaco, ALLERGAN unveiled Juvederm VOLUX. Juvederm VOLUX is the most recent addition to ALLERGAN's Juvederm facial filler range.

In April 2019, Merz Pharma released Belotero Revive, a dermal filler containing a rare mixture of glycerol and hyaluronic acid (HA) that is specifically engineered to increase elasticity, hydration, and firmness of the skin, as well as the appearance of fine lines.

Chapter 1   Methodology

1.1    Market Scope & Definitions

1.2    Estimates & Forecast Calculation

1.3    Historical Data Overview and Validation

1.4    Data Sources

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Facial Injectable Industry Overview, 2016-2026

2.1.1    Industry Overview

2.1.2    Product Overview

2.1.3    Application Overview

2.1.4    Regional Overview

Chapter 3   Facial Injectable Market Trends

3.1    Market Segmentation

3.2    Industry Background, 2016-2026

3.3    Market Key Trends

3.3.1    Positive Trends

3.3.1.1    Technology Advancement in Non-Invasive Beauty Treatments

3.3.1.2    The Rising Prevalence of Geriatric Patients for Beauty Treatments of Aged Skin

3.3.2    Industry Challenges

3.3.2.1    High Cost Associated With the Treatments in the Low Income Countries

3.4    Prospective Growth Scenario

3.4.1    Product Growth Scenario

3.4.2    Application Growth Scenario

3.5    COVID-19 Influence over Industry Growth

3.6    Porter’s Analysis

3.7    PESTEL Analysis

3.8    Value Chain & Supply Chain Analysis

3.9    Regulatory Framework

3.9.1    North America

3.9.2    Europe

3.9.3    APAC

3.9.4    LATAM

3.9.5    MEA

3.10    Technology Overview

3.11    Market Share Analysis, 2020

3.11.1    Company Positioning Overview, 2020

Chapter 4   Facial Injectable Market, By Product

4.1    Product Outlook

4.2    Hyaluronic Acid (HA)

4.2.1    Market Size, By Region, 2016-2026 (USD Million)

4.3    Calcium Hydroxyapatite (CaHA)

4.3.1    Market Size, By Region, 2016-2026 (USD Million)

4.4    Botulinum Toxin Type A

4.4.1    Market Size, By Region, 2016-2026 (USD Million)

4.4    Collagen

4.4.1    Market Size, By Region, 2016-2026 (USD Million)

4.4    Polymer Fillers

4.4.1    Market Size, By Region, 2016-2026 (USD Million)

Chapter 5   Facial Injectable Market, By Application

5.1    Application Outlook

5.2    Therapeutics

5.2.1    Market Size, By Region, 2016-2026 (USD Million)

5.3    Aesthetics

5.3.1    Market Size, By Region, 2016-2026 (USD Million)

Chapter 6   Facial Injectable Market, By Region

6.1    Regional outlook

6.2    North America

6.2.1    Market Size, By Country 2016-2026 (USD Million)

6.2.2    Market Size, By Product, 2016-2026 (USD Million)

6.2.3    Market Size, By Application, 2016-2026 (USD Million)

6.2.4    U.S.

6.2.4.1    Market Size, By Product, 2016-2026 (USD Million)

6.2.4.2    Market Size, By Application, 2016-2026 (USD Million)

6.2.5    Canada

6.2.5.1    Market Size, By Product, 2016-2026 (USD Million)

6.2.5.2    Market Size, By Application, 2016-2026 (USD Million)

6.3    Europe

6.3.1    Market Size, By Country 2016-2026 (USD Million)

6.3.2    Market Size, By Product, 2016-2026 (USD Million)

6.3.3    Market Size, By Application, 2016-2026 (USD Million)

6.3.4    Germany

6.3.4.1    Market Size, By Product, 2016-2026 (USD Million)

6.3.4.2    Market Size, By Application, 2016-2026 (USD Million)

6.3.5    UK

6.3.5.1    Market Size, By Product, 2016-2026 (USD Million)

6.3.5.2    Market Size, By Application, 2016-2026 (USD Million)

6.3.6    France

6.3.6.1    Market Size, By Product, 2016-2026 (USD Million)

6.3.6.2    Market Size, By Application, 2016-2026 (USD Million)

6.3.7    Italy

6.3.7.1    Market Size, By Product, 2016-2026 (USD Million)

6.3.7.2    Market Size, By Application, 2016-2026 (USD Million)

6.3.8    Spain

6.3.8.1    Market Size, By Product, 2016-2026 (USD Million)

6.3.8.2    Market Size, By Application, 2016-2026 (USD Million)

6.3.9    Russia

6.3.9.1    Market Size, By Product, 2016-2026 (USD Million)

6.3.9.2    Market Size, By Application, 2016-2026 (USD Million)

6.4    Asia Pacific

6.4.1    Market Size, By Country 2016-2026 (USD Million)

6.4.2    Market Size, By Product, 2016-2026 (USD Million)

6.4.3    Market Size, By Application, 2016-2026 (USD Million)

6.4.4    China

6.4.4.1    Market Size, By Product, 2016-2026 (USD Million)

6.4.4.2    Market Size, By Application, 2016-2026 (USD Million)

6.4.5    India

6.4.5.1    Market Size, By Product, 2016-2026 (USD Million)

6.4.5.2    Market Size, By Application, 2016-2026 (USD Million)

6.4.6    Japan

6.4.6.1    Market Size, By Product, 2016-2026 (USD Million)

6.4.6.2    Market Size, By Application, 2016-2026 (USD Million)

6.4.7    Australia

6.4.7.1    Market Size, By Product, 2016-2026 (USD Million)

6.4.7.2    Market size, By Application, 2016-2026 (USD Million)

6.4.8    South Korea

6.4.8.1    Market Size, By Product, 2016-2026 (USD Million)

6.4.8.2    Market Size, By Application, 2016-2026 (USD Million)

6.5    Latin America

6.5.1    Market Size, By Country 2016-2026 (USD Million)

6.5.2    Market Size, By Product, 2016-2026 (USD Million)

6.5.3    Market Size, By Application, 2016-2026 (USD Million)

6.5.4    Brazil

6.5.4.1    Market Size, By Product, 2016-2026 (USD Million)

6.5.4.2    Market Size, By Application, 2016-2026 (USD Million)

6.5.5    Mexico

6.5.5.1    Market Size, By Product, 2016-2026 (USD Million)

6.5.5.2    Market Size, By Application, 2016-2026 (USD Million)

6.5.6    Argentina

6.5.6.1    Market Size, By Product, 2016-2026 (USD Million)

6.5.6.2    Market Size, By Application, 2016-2026 (USD Million)

6.6    MEA

6.6.1    Market Size, By Country 2016-2026 (USD Million)

6.6.2    Market Size, By Product, 2016-2026 (USD Million)

6.6.3    Market Size, By Application, 2016-2026 (USD Million)

6.6.4    Saudi Arabia

6.6.4.1    Market Size, By Product, 2016-2026 (USD Million)

6.6.4.2    Market Size, By Application, 2016-2026 (USD Million)

6.6.5    UAE

6.6.5.1    Market Size, By Product, 2016-2026 (USD Million)

6.6.5.2    Market Size, By Application, 2016-2026 (USD Million)

6.6.6    South Africa

6.6.6.1    Market Size, By Product, 2016-2026 (USD Million)

6.6.6.2    Market Size, By Application, 2016-2026 (USD Million)

Chapter 7   Company Landscape

7.1    Competitive Analysis, 2020

7.2    Suneva Medical, Inc.

7.2.1    Company Overview

7.2.2    Financial Analysis

7.2.3    Strategic Positioning

7.2.4    Info Graphic Analysis

7.3    ALLERGAN

7.3.1    Company Overview

7.3.2    Financial Analysis

7.3.3    Strategic Positioning

7.3.4    Info Graphic Analysis

7.4    Sinclair Pharma

7.4.1    Company Overview

7.4.2    Financial Analysis

7.4.3    Strategic Positioning

7.4.4    Info Graphic Analysis

7.5    Merz Pharma

7.5.1    Company Overview

7.5.2    Financial Analysis

7.5.3    Strategic Positioning

7.5.4    Info Graphic Analysis

7.6    Prollenium Medical Technologies Inc.

7.6.1    Company Overview

7.6.2    Financial Analysis

7.6.3    Strategic Positioning

7.6.4    Info Graphic Analysis

7.7    Medytox, Inc

7.7.1    Company Overview

7.7.2    Financial Analysis

7.7.3    Strategic Positioning

7.7.4    Info Graphic Analysis

7.8    Galderma S.A.

7.8.1    Company Overview

7.8.2    Financial Analysis

7.8.3    Strategic Positioning

7.8.4    Info Graphic Analysis

7.9    Bloomage BioTechnology Corporation Limited

7.9.1    Company Overview

7.9.2    Financial Analysis

7.9.3    Strategic Positioning

7.9.4    Info Graphic Analysis

7.10    Anika Therapeutics, Inc.

7.10.1    Company Overview

7.10.2    Financial Analysis

7.10.3    Strategic Positioning

7.10.4    Info Graphic Analysis

7.11    Other Companies

7.11.1    Company Overview

7.11.2    Financial Analysis

7.11.3    Strategic Positioning

7.11.4    Info Graphic Analysis 

The Global Facial Injectable Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Facial Injectable Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global facial injectable market size is projected to grow CAGR value of 8.8% between 2021 to 2026.
Key and innovative vendors in the facial injectable market include Suneva Medical, Inc., ALLERGAN, Sinclair Pharma, Merz Pharma, Prollenium Medical Technologies Inc., Medytox, Inc., Galderma S.A., Bloomage BioTechnology Corporation Limited, Anika Therapeutics, Inc., and Ipse, among others.
The North American region is estimated to hold the largest share of the facial injectable market.
The market for facial injectables is expected to continue to grow owing to the rising demand for cosmetic surgeries owing to the growing number of people are becoming more conscious of their looks as they turn to video conferencing solutions.
The facial injectable market is driven by the growing demand for cosmetic solutions, low maintenance recovery period, rising geriatric population, and the growing awareness of beauty treatments.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius